Active substanceThioctic acidThioctic acid
Similar drugsTo uncover
  • Berlition® 300
    concentrate d / infusion 
  • Berlition® 300
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Berlition® 600
    concentrate d / infusion 
  • Lipoic acid
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • Lipoic acid
    pills inwards 
    MARBIOFARM, OJSC     Russia
  • Lipotyxon®
    concentrate d / infusion 
  • Neurolephone
    capsules inwards 
    FARMAK, PAO     Ukraine
  • Neurolephone
    concentrate d / infusion 
    FARMAK, PAO     Ukraine
  • Octolip®
    pills inwards 
  • Octolip®
    concentrate d / infusion 
  • Octolip®
    capsules inwards 
  • Polition
    concentrate in / in 
  • Tiogamma®
    solution d / infusion 
  • Tiogamma®
    pills inwards 
  • Thiocacid® 600 T
    solution in / in 
  • Tioctacid® BV
    pills inwards 
  • Thioctic acid
    pills inwards 
    ATOLL, LLC     Russia
  • Thioctic acid
    concentrate d / infusion 
    ATOLL, LLC     Russia
  • Thioctic acid-Vial
    pills inwards 
    VIAL, LLC     Russia
  • Thiolept®
    pills inwards 
  • Thiolept®
    solution d / infusion 
  • Thiolept®
    pills inwards 
  • Thiolept®
    concentrate d / infusion 
  • Thiolipon
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Thiolipon
    concentrate in / in 
    BIOSINTEZ, PAO     Russia
  • Espa Lipon
    pills inwards 
    Esparma GmbH     Germany
  • Espa Lipon
    concentrate d / infusion 
    Esparma GmbH     Germany
  • Dosage form: & nbspconcentrate for solution for infusion
    Composition:

    Active substance:

    Meglumine tioktat ** - 583.86 mg; - 1167.72 mg.

    in terms of tiectic acid (alpha-lipoic acid) - 300 mg; - 600 mg.

    Excipients:

    Macrogol (macrogol-300) - 2,400 mg; 4800 mg.

    Sodium sulfite anhydrous - 6 mg; -12 mg.

    Disodium edetate - 6 mg; -12 mg.

    Meglumine from 12.5 mg to 35 mg from 25 mg to 70 mg (up to a pH of 8.0 to 9.0); (to a pH of 8.0 to 9.0).

    Water for injection up to 12 ml; up to 24 ml.

    ** meglumine tioktat formed by reaction of thioctic acid 300 mg (600 mg) and meglumine 283.86 mg (567.72 mg)

    Description:

    Transparent liquid from light-yellow to greenish-yellow

    Pharmacotherapeutic group:Metabolic means
    ATX: & nbsp

    A.16.A.X.01   Thioctic acid

    Pharmacodynamics:

    Thioctic acid (alpha lipoic acid) - an endogenous antioxidant (binds free radicals), in the body is formed during the oxidative decarboxylation of alpha-keto acids. As a coenzyme mitochondrial multienzyme complexes is involved in the oxidative decarboxylation of pyruvic acid and alpha-keto acids. Helps reduce blood glucose levels and increase glycogen in the liver, as well as overcoming insulin resistance. By the nature of the biochemical action is close to the vitamins of group B. It participates in the regulation of lipid and carbohydrate metabolism, stimulates the exchange of cholesterol, improves liver function. Has hepatoprotective, hypolipidemic, hypocholesterolemic, hypoglycemic action. Improves trophic neurons.

    Pharmacokinetics:

    With intravenous administration, the time to reach the maximum concentration is 10-11 minutes, the maximum concentration is 25-38 μg / ml, the area under the concentration-time curve is about 5 μg h / ml. Bioavailability is 30%.

    Thioctic acid has the effect of "first passage" through the liver. The formation of metabolites occurs as a result of oxidation of the side chain and conjugation.

    The volume of distribution is about 450 ml / kg. Thioctic acid and its metabolites are excreted by the kidneys (80-90%). Half-life is 20-50 minutes. Total Plasma clearance 10-15 ml / min.

    Indications:
    Diabetic polyneuropathy; alcoholic polyneuropathy.
    Contraindications:

    Hypersensitivity to the components of the drug;

    children under 18 years of age (efficacy and safety of use not established).

    Pregnancy and lactation:
    The use during pregnancy and the period of breastfeeding is contraindicated.
    Dosing and Administration:

    The preparation is intended for the preparation of a solution for infusions after preliminary dilution in isotonic sodium chloride solution.

    When severe forms of diabetic or alcoholic polyneuropathy should be administered 300-600 mg once a day in the form of intravenous drip infusion. Intravenous infusion should be administered within 50 minutes. The drug is recommended for 2-4 weeks.

    Then you can continue to take thioctic acid inside at a dose of 300-600 mg per day. The minimum duration of treatment with pills is 3 months.

    Side effects:

    With intravenous administration, convulsions are rarely possible; diplopia; point bleeding in mucous membranes, skin; thrombocytopathy; hemorrhagic rash (purpura), thrombophlebitis.

    With rapid administration, it is possible to increase intracranial pressure (the appearance of a feeling of heaviness in the head); difficulty breathing. The listed side effects go by themselves.

    Allergic reactions are possible: urticaria, systemic allergic reactions (up to the development of anaphylactic shock).

    Possible the development of hypoglycemia (in connection with improving the absorption of glucose).

    Overdose:

    Symptoms: headache, nausea, vomiting.

    Treatment: symptomatic. There is no specific antidote.

    Interaction:

    Alpha-lipoic acid (in the form of a solution for infusions) leads to a decrease in the effect of cisplatin.

    With simultaneous use with insulin and other oral hypoglycemic agents, an increase in the hypoglycemic effect is observed. Alpha-lipoic acid forms hardly soluble complex compounds with sugar molecules (for example, a solution of levulose), therefore, it is incompatible with glucose solution, Ringer's solution, and also with compounds (including their solutions) reacting with disulfide and SH-groups .

    Special instructions:

    In patients with diabetes, especially at the beginning of treatment, frequent monitoring of the concentration of glucose in the blood.In some cases, a reduction in the dose of hypoglycemic agents is required.

    During treatment, it is necessary to strictly refrain from drinking alcohol, because when the effect of alcohol therapeutic effect of thioctic acid is weakened. The preparation possesses photosensitivity, therefore it is necessary to take ampoules from the package just before use. It is advisable to protect the bottle with solution from light during the infusion (light-protective bags, aluminum foil can be used). The prepared solution should be stored in a dark place and used for a maximum of 6 hours after cooking.

    Form release / dosage:

    Concentrate for solution preparation for infusions of 25 mg / ml.

    Packaging:

    For 12 ml or 24 ml in ampoules light-protective glass with colored ring fracture or with a color dot and a notch.

    Ampoules are additionally applied one, two or three color rings and / or a two-dimensional barcode, and / or alphanumeric encoding or without additional color rings, a two-dimensional barcode, alphanumeric coding.

    5 ampoules per contour cell packaging from polyvinyl chloride and aluminum foil or foil polymer or without foil and film; or in a planar cell pack with an integral film cover polyvinyl chloride.

    1 outline cell pack together with instructions for use in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of 15 to 25 ° C.

    Keep out of the reach of children.

    Shelf life:
    2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LSR-003089/08
    Date of registration:24.04.2008 / 07.08.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:FarmSirma Soteks, ZAO FarmSirma Soteks, ZAO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp10.04.2018
    Illustrated instructions
      Instructions
      Up